Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer

Abstract

BackgroundApproximately 30 % of breast cancer patients receive chemotherapy, yet little is known about influences of current regimens on circulating lymphocyte levels and phenotypes. Similarly, clinico-pathological factors that modify these influences, and implications for future immune health remain mainly unexplored.MethodsWe used flow-cytometry to assess circulating lymphocyte levels and phenotypes in 88 primary breast cancer patients before chemotherapy and at time-points from 2 weeks to 9 months after chemotherapy completion. We examined circulating titres of antibodies against pneumococcal and tetanus antigens using ELISAs.ResultsLevels of B, T and NK cells were significantly reduced 2 weeks after chemotherapy (p < 0.001). B cells demonstrated particularly dramatic depletion, falling to 5.4 % of pre-chemotherapy levels. Levels of all cells recovered to some extent, although B and CD4+ T cells remained significantly depleted even 9 months post-chemotherapy (p < 0.001). Phenotypes of repopulating B and CD4+ T cells were significantly different from, and showed no sign of returning to pre-chemotherapy profiles. Repopulating B cells were highly depleted in memory cells, with proportions of memory cells falling from 38 % to 10 % (p < 0.001). Conversely, repopulating CD4+ T cells were enriched in memory cells, which increased from 63 % to 75 % (p < 0.001). Differences in chemotherapy regimen and patient smoking were associated with significant differences in depletion extent or repopulation dynamics. Titres of anti-pneumococcal and anti-tetanus antibodies were both significantly reduced post-chemotherapy and did not recover during the study (p < 0.001).ConclusionBreast cancer chemotherapy is associated with long-term changes in immune parameters that should be considered during clinical management.Electronic supplementary materialThe online version of this article (doi:10.1186/s13058-015-0669-x) contains supplementary material, which is available to authorized users.

Pregnancy after cancer: Does timing of conception affect infant health?

“…18,19 Studies have indicated that immunosuppression in patients with breast cancer persists months or years after chemotherapy, with CD4-positive counts at one-half of pretreatment levels 12 to 14 months after treatment, 20,21 and weaker vaccine responses in breast cancer survivors with a mean of 2.6 years since chemotherapy. 18,19 Studies have indicated that immunosuppression in patients with breast cancer persists months or years after chemotherapy, with CD4-positive counts at one-half of pretreatment levels 12 to 14 months after treatment, 20,21 and weaker vaccine responses in breast cancer survivors with a mean of 2.6 years since chemotherapy.…”

Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients

“…However, such very long-lasting effects seem unlikely considering that NK cell numbers quickly recover after chemotherapy 58 and cytotoxicity is restored quickly even after maximally invasive procedures like allogeneic transplantation 59 …”

Understanding the reconstitution of the B‐cell compartment in bone marrow and blood after treatment for B‐cell precursor acute lymphoblastic leukaemia

“…The normal B‐cell compartment can be severely affected in patients receiving chemotherapy regimens (Steele, ; Lehrnbecher et al , ). Profound B‐lymphocytopenia as a result of chemotherapy was previously reported in patients with solid tumours treated with docetaxel, patients with breast cancer treated with anthracycline‐based regimens and patients with acute lymphoblastic leukaemia (ALL) treated with multidrug chemotherapy (Kotsakis et al , ; van Lochem et al , ; van Wering et al , ; Eyrich et al , ; van Tilburg et al , ; Wiegering et al , ; Verma et al , ). In the latter patients, T‐cells, particularly CD8 + T‐cells, are significantly less affected by chemotherapy (Ek et al , ; Lehrnbecher et al , ; van Tilburg et al , ).…”